Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Manzanillo who wrote (28542)	2/20/1999 9:09:00 AM
From: Bill Wexler	Read Replies (2) \| Respond to of 31646

I know when to hold 'em. The conclusion of the Zonagen fraud will depend on the final FDA decision. Bookmark this post...Vasomax will be rejected. Since the company is still a fundamental mess, has no viable product, no real revenues and massive losses, then it doesn't make any sense to "move on". The correct strategy in this case is to short on any runups...which I have done. Between now and FDA rejection, the stock price can be all over the map due to high short interest and constant fraudulent promotion. The only reason the stock price is above 5 is that victims are betting that Vasomax will be approved. They are wrong. <<So far you are losing your shirt.>> You're a fool.